Evaluation of transmyocardial laser revascularization by following objective parameters of perfusion and ventricular function

Thoracic and Cardiovascular Surgeon

Volumn 48, Issue 2, 2000, Pages 79-85

  Lutter, G ^a,b   Sarai, K ^a   Nitzsche, E ^a   Saurbier, B ^a   Frey, M ^a   Hoegerle, S ^a   Martin, J ^a   Zipfel, M ^a   Spillner, G ^a   Beyersdorf, F ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Coronary disease; Ischemia; Myocardium; Revascularization; Transmyocardial laser revascularization

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EVALUATION; FEMALE; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; CARDIAC OUTPUT; CORONARY ARTERY BYPASS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; VENTRICULAR FUNCTION;

EID: 17144435637     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9872     Document Type: Article

References (31)

1. Mirhoseini M, Shelgikar S, Cayton MM. New concepts in revascularization of the myocardium. Ann Thorac Surg. 1988; 45 : 415-20.
2. Frazier OH, Kadipasaoglu KA, Cooley DA. Transmyocardial laser revascularization. Does it have a role in the treatment of ischemic heart disease? Tex Heart Inst J. 1998;25 : 24-9.
3. 2 laser: one year results of a randomized, controlled trial. Sem Thorac Cardiovasc Surg. 1999;11 : 12-8.
4. Horvath KA, Cohn LH, Cooley DA, et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease.JThoracCardiovascSurg. 1997;113 : 645-54.
5. Cooley DA, Frazier OH, Kadipasaoglu KA, et al. Transmyocardial laser revascularization: clinical experience with 12-month follow-up. J Thorac Cardiovasc Surg. 1996;111 : 791-9.
6. Lutter G, Frey M, Saurbier B, et al. Treatment option for patients with otherwise intractable angina pectoris: transmyocardial laser revascularization. Z Kardiol. 1998;87 (Suppl. 2) : 199-202.
7. Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353 : 519-24.
8. Naegele H, Stubbe HM, Nienaber C, Rödiger W. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up. Eur Heart J. 1998;19:1525-30.
9. Lutter G, Yoshitake M, Takahashi N, et al. Transmyocardial laser-revascularization: experimental studies on prolonged acute regional ischemia. Eur J Cardio-thorac Surg. 1998;13 : 694-701.
10. Lutter G, Schwarzkopf J, Takahashi N, Yoshitake M, Nitzsche E, Martin J, Beyersdorf F. Transmyocardial laser revascularization: experimental studies in healthy porcine myocardium. Ann Thorac Surg. 1999;67 : 1708-13.
11. Lutter G, Martin J, Köster F, et al. Analysis of the new indirect revascularization method by determining objective parameters of clinical chemistry, histo-chemistry and histology. Eur J Cardio-thorac Surg. 1999; 15 : 709-16.
12. Lutter G, Saurbier B, Nitzsche E, et al. Transmyocardial laser revascularization (TMLR) in patients with unstable angina and low ejection fraction. Eur J Cardio-thorac Surg. 1998;13 : 21-6.
13. Lucignani G, Paolini G, Landoni C, et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. EurJ Nucl Med. 1992;19 : 874-81.
14. Di Carli M, Sherman T, Khanna S, et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23 : 860-8.
15. Braunwald E. Unstable Angina. A classification. Circulation. 1989;80 : 410-14.
16. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiography. 1989;2 : 358-67.
17. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW. Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation. 1986;74 : 293-305.
18. Frazier OH, Cooley DA, Kadipasaoglu KA, et al. Myocardial revascularization with laser - preliminary findings. Circulation. 1995;92 (Suppl. II) : II58-II 65.
19. Rimoldi O, Burns SM, Rosen SD, Wistow E, Schofield PM, Camici PG. Measurements of myocardial blood flow with positron emission tomography before and after transmyocardial revascularization (abstract). Circulation. 1998;98 (Suppl. I) : I407-I407.
20. Moosdorf R. Transmyocardial laser revascularization. Z Kardiol. 1997;86 : 115-24.
21. Jones RH, Kesler K, Phillips III HR, et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 1996;111 : 1013-25.
22. Lutter G, Schwarzkopf J, Lutz C, Martin J, Beyersdorf F. Histologic findings of transmyocardial laser channels after two hours. Ann Thorac Surg. 1998;65 : 1437-9.
23. Mirhoseini M, Shelgikar S, Cayton MM. New concepts in revascularization of the myocardium. Ann Thorac Surg. 1988;45 : 415-20.
24. Fleischer KJ, Goldschmidt-Clermont PJ, Fonger JD, Hutchins GM, Hruban RH, Baumgartner WA. One-month histologic response of transmyocardial laser channels with molecular intervention. Ann Thorac Surg. 1996;62 : 1051-8.
25. 2 laser-induced intramyocardial revascularization. Basic Res Cardiol. 1990;85 : 179-97.
26. 2 and Holmium:YAG lasers. Ann Thorac Surg. 1997;64 : 466-72.
27. Mack CA, Magovern CJ, Hahn RT, SanbornT, Lanning L, Ko W, Isom OW, Rosengart TK. Channel patency and neovascularization after transmyocardial revascularization using an eximer laser. Circulation. 1997;96 (Suppl. II) : II65-II69.
28. Horvath KA, Greene R, Belkind N, Kane B, McPherson DD, Fullerton DA. Left ventricular functional improvement alter transmyocardial laser revascularization. Ann Thorac Surg. 1998;66 : 721-5.
29. Kwong KF, Kanellopoulos GK, Nickols JC, Pogwidz SM, Saffitz JE, Schuessler RB, Sundt III TM. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg. 1997;114 : 883-90.
30. Al-Sheikh T, Allen KB, Straka SP, et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation. 1999;100 : 135-40.
31. Arora RC, Thompson GW, Hirsch GM. Transmyocardial laser revascularization does not denervate the heart. Circulation. 1998;17 (Suppl. I) : I541-I541.